---
figid: PMC9123899__keab673f2
figtitle: 'Interfering with interferons: targeting the JAK-STAT pathway in complications
  of systemic juvenile idiopathic arthritis (SJIA)'
organisms:
- NA
pmcid: PMC9123899
filename: keab673f2.jpg
figlink: /pmc/articles/PMC9123899/figure/keab673-F2/
number: F2
caption: IFN crosstalk and signalling pathway modulation(A) Type I and II IFNs modulate
  the immune response by epigenomic changes. IFN-γ inhibits the anti-inflammatory
  response of IL-10 by interfering with STAT3 signalling. IFNα/β signalling via IFNAR
  and DAMPs/PAMPs signalling via TLRs can work together to induce transcriptional
  regulation of IL-18. (B) IFNα/β downregulates IL-1α/β by upregulation of IL-10,
  IL1RA and the decoy IL-1R2 receptor. IL-1 suppresses IFNα/β production via Prostaglandin
  E2 (PGE2) upregulation. Anakinra/Canakinumab, which blocks IL-1 signalling, can
  thus promote increased IFNα/β levels.
papertitle: 'Interfering with interferons: targeting the JAK-STAT pathway in complications
  of systemic juvenile idiopathic arthritis (SJIA).'
reftext: Emely L Verweyen, et al. Rheumatology (Oxford). 2022 Mar;61(3):926-935.
year: '2022'
doi: 10.1093/rheumatology/keab673
journal_title: Rheumatology (Oxford, England)
journal_nlm_ta: Rheumatology (Oxford)
publisher_name: Oxford University Press
keywords: systemic JIA | macrophage activation syndrome | lung disease | interferon
  | JAK-STAT
automl_pathway: 0.8837804
figid_alias: PMC9123899__F2
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC9123899__F2
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC9123899__keab673f2.html
  '@type': Dataset
  description: IFN crosstalk and signalling pathway modulation(A) Type I and II IFNs
    modulate the immune response by epigenomic changes. IFN-γ inhibits the anti-inflammatory
    response of IL-10 by interfering with STAT3 signalling. IFNα/β signalling via
    IFNAR and DAMPs/PAMPs signalling via TLRs can work together to induce transcriptional
    regulation of IL-18. (B) IFNα/β downregulates IL-1α/β by upregulation of IL-10,
    IL1RA and the decoy IL-1R2 receptor. IL-1 suppresses IFNα/β production via Prostaglandin
    E2 (PGE2) upregulation. Anakinra/Canakinumab, which blocks IL-1 signalling, can
    thus promote increased IFNα/β levels.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - IFN1@
  - IFNA1
  - IFNA2
  - IFNA17
  - IFNA4
  - IFNA5
  - IFNA6
  - IFNA7
  - IFNA8
  - IFNA10
  - IFNA13
  - IFNA14
  - IFNA16
  - IFNA21
  - IFNB1
  - IFNG
  - IL10
  - STAT3
  - ADM
  - YME1L1
  - TLR1
  - TLR2
  - TLR3
  - TLR4
  - TLR5
  - TLR6
  - TLR7
  - TLR8
  - TLR9
  - TLR10
  - NFKB1
  - RELA
  - RELB
  - REL
  - NFKB2
  - SOAT1
  - STAT1
  - STAT2
  - STAT4
  - STAT6
  - STAT5A
  - STAT5B
  - IFNAR1
  - IFNAR2
  - IL1RN
  - IL6R
  - IL1R1
  - IL1R2
  - IL1B
  - IL13
---
